Multiple myeloma is a cancer of plasma cells. Normal plasma cells are found in the bone marrow (the soft, inner parts of certain bones where new blood cells are made). They are an important part of ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

Dr. Clark went on to explain to Hart that there was a significant therapeutic advancement in 2017 for the treatment of blood cancers like multiple myeloma with the FDA approval of what is known as ...

During a Case-Based Roundtable® event, Robert Z. Orlowski, MD, PhD, discussed the case of a patient who had progression of ...

Please note there are only 20 spaces available on the course. Students will then have the opportunity to complete Lab Report's if they wish to be awarded credits for the course. This can be completed ...

Rocket Lab reported earnings last week, but that's not all the news it shared. It's also planning a floating landing pad, and it has invented a flatter satellite. It also doubled one launch ...

The Private Sector Investment lab is a collaborative initiative between the World Bank Group and CEOs of leading global private sector institutions. Its goal is to develop solutions that address ...

Forty-eight patients with multiple myeloma, most of them ambulatory outpatients, at 5 co-operating hospitals,‡ were treated. Patients were entered in the double-blind study by randomized card ...

Background: Multiple myeloma (MM), a malignant disease of plasma cells originating in the bone marrow, is influenced significantly by genetic factors. Although plasma liposomes have been linked to MM, ...

Oncolytic virotherapy represents an innovative and promising approach for the treatment of cancer, including multiple myeloma (MM), a currently incurable plasma cell (PC) neoplasm. Despite the ...

Preliminary results indicate that in relapsed/refractory multiple myeloma patients who have previously received two immunomodulatory drugs (lenalidomide and pomalidomide), at least one proteasome ...